Sun Pharmaceutical Industries Reports 19.14% Surge in Open Interest to 91,886 Contracts
Sun Pharmaceutical Industries Ltd has seen a notable rise in open interest, reaching 91,886 contracts, alongside a trading volume of 54,496 contracts, indicating increased market activity. Despite a slight decline in stock price, the company maintains a strong position relative to its moving averages and holds a significant market capitalization.
Sun Pharmaceutical Industries Ltd (SUNPHARMA) has experienced a significant increase in open interest today, reflecting heightened activity in the derivatives market. The latest open interest stands at 91,886 contracts, up from the previous figure of 77,125, marking a change of 14,761 contracts or a 19.14% increase. This surge in open interest comes alongside a trading volume of 54,496 contracts, indicating robust engagement from market participants.In terms of price performance, Sun Pharma is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a strong position relative to its recent historical performance. However, the stock has seen a slight decline of 0.28% today, while the broader sector has also experienced a minor drop of 0.24%. Notably, the delivery volume on October 24 was recorded at 614,000 shares, which represents a significant decrease of 51.09% compared to the 5-day average delivery volume, indicating a potential shift in trading dynamics.
With a market capitalization of Rs 4,06,519.32 crore, Sun Pharmaceutical Industries remains a key player in the Pharmaceuticals & Biotechnology sector. The increase in open interest, coupled with the current trading metrics, underscores the evolving landscape for this large-cap stock.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
